Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes
Antibodies · 01.04.2024 · 13 (2) · 27
DOI: 10.3390/antib13020027 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibodies, online erschienen am 01.04.2024. Verfasst von Lindsay E Bass und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAMS NIH HHS, National Institutes of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Islet autoantibodies predict type 1 diabetes (T1D) but can be transient in murine and human T1D and are not thought to be directly pathogenic. Rather, these autoantibodies signal B cell activity as antigen-presenting cells (APCs) that present islet autoantigen to diabetogenic T cells to promote T1D pathogenesis. Disrupting B cell APC function prevents T1D in mouse models and has shown promise in clinical trials. Autoantigen-specific B cells thus hold potential as sophisticated T1D biomarkers and therapeutic targets. B cell receptor (BCR) somatic hypermutation is a mechanism by which B cells increase affinity for islet autoantigen. High-affinity B and T cell responses are selected in protective immune responses, but immune tolerance mechanisms are known to censor highly autoreactive clones in autoimmunity, including T1D. Thus, different selection rules often apply to autoimmune disease settings (as opposed to protective host immunity), where different autoantigen affinity ceilings are tolerated based on variations in host genetics and environment. This review will explore what is currently known regarding B cell signaling, selection, and interaction with T cells to promote T1D pathogenesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- Vanderbilt Institute for Infection, Immunology and Inflammation, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
ORCID-Profile: Rachel H Bonami
Förderung
- NIDDK NIH HHS
- NIAMS NIH HHS
- National Institutes of Health
Zitieren
APA
Bass, L. E., & Bonami, R. H. (2024). Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes. Antibodies, 13(2), 27. https://doi.org/10.3390/antib13020027
Vancouver
Bass LE, Bonami RH. Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes. Antibodies. 2024;13(2):27. doi:10.3390/antib13020027
BibTeX
@article{Bass2024,
author = {Bass, Lindsay E and Bonami, Rachel H},
title = {Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes},
journal = {Antibodies},
year = {2024},
volume = {13},
number = {2},
pages = {27},
doi = {10.3390/antib13020027}
}
EUVIMED